Specialists define and discuss extrapolation, along with the importance of strong data in specific disease states. This is a video synopsis/summary of a panel discussion involving Ryan Haumschild, ...

Brazilian oncologists showed a solid knowledge base about biosimilars and their safety; however, concerns over extrapolation and interchangeability requirements remained, suggesting that more ...

There are critical gaps in biosimilar adoption for pediatric patients, focusing on safety, regulatory challenges, and the ...

The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created an abbreviated licensure pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed ...

Please provide your email address to receive an email when new articles are posted on . Biosimilars are a promising option that might expand access to retinal therapies, reducing costs and improving ...